Items tagged with TB care

Mozambique health care workers speak on struggle to control tuberculosis (post)

Health care workers in Mozambique voiced concerns about the obstacles confronting them as they struggle to control tuberculosis (TB), in a study recently published in the science and medicine journal PLOS ONE.

Tuberculosis: a joint MSF/Ministries of Health symposium to discuss new treatments and approaches in Eastern Europe and Central Asia (post)

A medical forum in Armenia gathers health authorities and specialists to discuss tuberculosis, one of the main public health issues in the region. New drugs and therapeutic approaches give hope of better treatment outcomes. Joint and renewed efforts are needed to obtain a better access to the most effective drugs and new treatment regimens for the resistant form of the disease.

U.S. Government extends commitment to combat tuberculosis in Ethiopia (post)

New five-year activity will strengthen collaborative effort against drug-resistant TB

Scaling up multidrug-resistant tuberculosis care in China (post)

Drug-resistant tuberculosis threatens to undermine advances in tuberculosis control worldwide. Multidrug-resistant tuberculosis (MDRTB), defined as resistance to isoniazid and rifampicin, requires treatment for up to 24 months with expensive diagnostics and second-line drugs. Fewer than 15% of patients diagnosed with tuberculosis worldwide receive drug susceptibility testing (DST); only 20% of the estimated 480 000 new cases of MDRTB annually are treated appropriately.1 Of these, cure rarely exceeds 65%. Those on ineffective therapy risk acquiring additional resistance and spreading drug-resistant tuberculosis to others. In recent years, new molecular diagnostics and antituberculosis drugs promise an opportunity to improve outcomes for patients with drug-resistant tuberculosis, leading the WHO to prioritise universal access to prevention, diagnosis, and treatment of MDRTB.1 However, identification of viable models for coordinating and financing scale-up of such services remains a major challenge for most middle-income and low-income countries.

Indian doctors find success in tackling the 'invisible burden' of tuberculosis (post)

When Indian street-food seller Kumar Pal first began treatment for multi-drug resistant tuberculosis two years ago, he quickly spiraled into depression and gave up hope of living.

India: TB drug reminder services launched (post)

Apollo Hospitals, Hyderabad and The Union (International Union against Tuberculosis and Lung Disease) have introduced a Tuberculosis (TB) intervention programme that will send reminders to patients about administration of drugs and also notify cases to authorities.

Ukraine: Concurrent treatment for HIV/TB co-infection breaks up “deadly alliance” (post)

In a continuation of World TB Day coverage, the following guest post from study authors Martha Priedeman Skiles and Stephanie Mullen tells how current data from Ukraine show promise for patients co-infected with TB and HIV.

Page 3 of 44 · Total posts: 0

←First 2 3 4 Last→